41 – 50 of 134
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Molecular and Serologic Diagnostic Technologies for SARS-CoV-2
2022) In arXiv.org(
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Clinically observed deletions in SARS-CoV-2 Nsp1 affect its stability and ability to inhibit translation
(
- Contribution to journal › Article
-
Mark
Functional Antibodies Against SARS-CoV-2 Receptor Binding Domain Variants with Mutations N501Y or E484K in Human Milk from COVID-19-Vaccinated, -Recovered, and -Unvaccinated Women
(
- Contribution to journal › Article
-
Mark
Computational Analysis Reveals Monomethylated Triazolopyrimidine as a Novel Inhibitor of SARS-CoV-2 RNA-Dependent RNA Polymerase (RdRp)
(
- Contribution to journal › Article
-
Mark
Spike-Dependent Opsonization Indicates Both Dose-Dependent Inhibition of Phagocytosis and That Non-Neutralizing Antibodies Can Confer Protection to SARS-CoV-2
(
- Contribution to journal › Article
-
Mark
Can They Stay or Will They Go? : A Cross Sectional Study of Managers' Attitudes towards Their Senior Employees
(
- Contribution to journal › Article
-
Mark
Computational Evidence Based Perspective on the Plausible Repositioning of Fluoroquinolones for COVID-19 Treatment
(
- Contribution to journal › Article
-
Mark
NMR Observation of Sulfhydryl Signals in SARS-CoV-2 Main Protease Aids Structural Studies
(
- Contribution to journal › Article
-
Mark
Post-covid medical complaints following infection with SARS-CoV-2 Omicron vs Delta variants
(
- Contribution to journal › Article
-
Mark
SARS-CoV-2 in size-fractionated aerosols from hospital corridors and relations to the indoor environment
(
- Contribution to conference › Abstract